STUDY HYPOTHESIS AND DESCRIPTION
Identifying ME/CFS biomarkers will aid in the development of disease risk prediction and improve the clinical stratification of symptomatic patients. Ultimately, the discovery of biomarkers may lead to diagnoses that are more accurate, disease prevention measures, and indications on how to treat ME/CFS effectively.
We also we intend to investigate specific targets to determine their clinical utility for the elaboration of novel therapeutic approaches to treat the main symptoms associated with ME/CFS (e.g., PEMS, POTS, sleep disturbances and fatigue). We intend to develop better clinical tools allowing clinicians to diagnose ME/CFS and select the best treatments to address their medical needs.
OBJECTIVES
Donate your appreciated stock directly to OMFCA and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).
OMFCA sells your securities and uses the proceeds to support our mission. You also do not pay capital gains tax on the transfer when the stock is sold. Giving appreciated stock can be more beneficial than giving cash. The “cost” of your gift is often less than the deduction you gain by making it. In advance, thank you for making this generous gift.
Gifting of Stock Instructions
Brokerage/Investment Firm: TD Waterhouse
Name on the Account: Open Medicine Foundation Canada
Account Number: 20LRHLA
OMFCA Canadian Revenue Agency (CRA) charity registration #: 74926 5518 RR0001
OMF Canada Registered Address:
Open Medicine Foundation Canada
2987 Baynes Road, Victoria, BC V8N-1Y4
Phone Number: 416-848-0055
Please speak to your personal tax advisor and then call OMFCA at 650-242-8669 to notify us of your donation or with any questions.